| Name | 6β-Naltrexol |
|---|---|
| Synonyms |
6β-Naltrexol solution
6-β-Naltrexol hydrate in methanol 6-Hydroxynaltrexone 6β-Naltrexol (CRM) 6 beta-hydroxynaltrexone (5a,6a)-17-(Cyclopropylmethyl)-4,5-oxy-morphinan-3,6,14-triol 6β-Naltrexol (1.0 mg/mL in Methanol) 6b-Naltrexo Nalfurafine Impurity 30 17-(CyclopropylMethyl)-4,5-oxy-(5α,6β)-Morphinan-3,6,14-triol 17-(Cyclopropylmethyl)-4,5-oxy-(5a,6b)-morphinan-3,6,14-triol NALTREXOL a-Naltrexol 6a-Hydroxynaltrexone 6-beta-Naltrexol, 1mg/ml in Methanol (4R,4aS,7R,7,12bS)-3-(cyclopropylmethyl)-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol 17-(Cyclopropylmethyl)-4,5a-oxy-morphinan-3,6a,14-triol 6-Naltrexol 6-BETA-NALTREXOL HCL 6-β-Naltrexol HCl 6β-Naltrexol (1.0mg/ml in DMSO) (4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol 6b-Hydroxynaltrexone b-Naltrexol Naltrexone Impurity 31 Morphinan-3,6,14-triol, 17-(cyclopropylmethyl)-4,5-oxy-, (5α,6β) 6.beta.-Naltrexol (CRM) 17-(Cyclopropylmethyl)-4,5-oxy-(5a,6)-morphinan-3,6,14-triol |
| Description | 6β-Naltrexol (6β-Hydroxynaltrexone), the primary metabolite of Naltrexone, is a peripherally selective opioid antagonist. 6β-Naltrexol selectively inhibits gastrointestinal opioid effects in human subjects and inhibits Morphine-induced slowing of gastrointestinal transit[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.48g/cm3 |
|---|---|
| Boiling Point | 557.5ºC at 760mmHg |
| Melting Point | 90-96ºC |
| Molecular Formula | C20H25NO4 |
| Molecular Weight | 343.42 |
| Flash Point | 291ºC |
| Exact Mass | 343.17800 |
| PSA | 73.16000 |
| LogP | 1.25510 |
| Index of Refraction | 1.719 |
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |